期刊文献+

通过ROC曲线评估CA19-9对胰腺癌侵犯血管的诊断价值 被引量:2

Evaluation of the Diagnostic Value of CA19-9 to the Blood Vessel Invasion of Pancreatic Carcinoma by ROC Curve
暂未订购
导出
摘要 目的探讨胰腺癌时CA19-9升高与血管侵犯的关系,应用受试者工作特征(ROC)曲线为CA19-9的临床应用提供更有力的理论支持。方法将经病理证实的我院222例胰腺癌患者分为血管侵犯组和未侵犯组。首先以常规统计学方法比较两组间的CA19-9水平是否具有差异,其次通过ROC曲线进一步评估CA19-9的应用价值,最后比较CA19-9与CA125及CA242的临床价值。结果(1)在血管侵犯发生者中,CA19-9平均为294.6±37.9u/ml,而无血管侵犯者CA19-9平均水平为185.6±23.9u/ml,两者具有显著差异(P=0.016)。(2)CA19-9诊断胰腺癌血管侵犯的ROC曲线下面积为0.641。当CA19-9大于500u/ml时,其判断血管侵犯的特异性高达95%。(3)CA125与CA242的ROC曲线下面积分别为0.562和0.618。结论CA19-9的水平与肿瘤是否发生血性转移有一定关系,CA19-9在常用血清标志物中较CA125与CA242中诊断价值更高。通过ROC曲线可确知当CA19-9大于500u/ml时,判断肿瘤转移的特异性高达95%以上,这为CA19-9的应用提供了一定的临床支持,同时显示ROC曲线在诊断试验中较常用的方法敏感性和特异性更为优越,能够提供更多的信息。 Objective To investigate the diagnostic value of CA19-9 to the vessel invasion of pancreatic carcinoma by ROC curve. Methods 222 patients of pancreatic carcinoma were divided into two groups by the occurrence of vessel invasion or not. Compare the level of serum CA19-9 between these two groups and assess the value by ROC curve finally,CA125 and CA242 were compared to CA19-9 in the diagnostic value of vessel invasion. Results The serum level of CA19-9 was higher in the vessel invasion group than another group(294.6 ± 37.9 u/ml vs 185.6 ± 23.9 u/ml, P = 0. 016). In this test, the area of ROC curve is 0.641, higher than that of CA125 (0. 562 ) and CA242 (0.618 ). In addition, the specificity is above 95 % in the diagnosis of vessel invasion while serum level of CA19-9 is 500 u/ml or more. Conclusion Serum level of CA19-9 may relate to the occurrence of vessel invason. Possibly CA19-9 is the best serum marker in this test and when its level is beyond 500 u/ml, the specificity can get to 95%. ROC curve is better because it can offer more information than sensitivity and specificity.
出处 《临床消化病杂志》 2010年第2期110-112,共3页 Chinese Journal of Clinical Gastroenterology
关键词 胰腺癌 ROC曲线 支持血管 Pancreatic carcinoma ROC curre Blood vessel
  • 相关文献

参考文献12

二级参考文献30

  • 1金洲祥,马泳泳,黄生福,李永国.蛋白芯片法检测CA242,CA19-9和CEA对胰腺癌诊断价值[J].中国医学工程,2004,12(5):40-42. 被引量:4
  • 2戴奇,季步天,金凡,徐敏,高玉堂.上海市区胰腺癌全人群病例对照研究──胰腺癌与烟、酒、绿茶的关系[J].肿瘤,1996,16(1):5-10. 被引量:5
  • 3Coloey SC,Strickland NH,Walker JD,et al.Spiral CT and the pre-operative assessment of pancreatic adenocarcinoma [J]. Clinical Radiology, 1997, 52 (1): 54-60.
  • 4Kau SY, Shyr YM, Su CH, et al. Diagnostic and prognostic value of CA19 - 9and CEA in periampullary cancers [ J ]. J Am Coll Surh, 1999, 188 (4): 415-420.
  • 5Tian FZ, Appert HE, Mules F J, et al. prognostic value of serum CA19 - 9 levels in pancreatic adenocarcinoma [J]. Ann Surg, 215 (4): 350-355.
  • 6Japanese Pancreas Society. General rules for surgical and pathological studies on cancer of the pancreas. 3^rd [M]. Tokyo: Kanehara publishing, 1986: 32-36.
  • 7DelVillano BC, Zurzwski VR. The carbohydrate arltigenic determinant 19- 9 (CA- 19- 9): a monoclonal antibody defined tumor marker In immunodiagnostics [ M ]. New York, Alan Liss, 1983: 269-282.
  • 8Satake k. A clinical evaluation of carbohydrate antigen 19-9 (CA19-9) and carcinoembronie antigen (CEA) in patients with pancreatic carcinoma [ M ]. J Surg Oncol, 1985, 29 (1): 15-21.
  • 9Forkm CE, Lam biase L, Vogel SB. Diagnosis of pancreatic cancer and predictiou of unresectability using the tumor associated antigen CA19 - 9 [J]. Pancreas, 1994, 9 (6): 731-734.
  • 10Glenn J, Steinverg WM, Kurtunan SH et al. Evaluation of the utility of a radioimmunoassay for serum CA19 - 9 levels in patients before and after treatment of carcinoma of the pancreas [J]. J Clin Oncol, 1988, 6 (4): 462.

共引文献121

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部